The Phoenix Heart—PICSO and the Rebirth of Embryonic Life in the Ischemic Myocardium

TL;DR

This paper explores how a heart treatment called PICSO may trigger regenerative processes by reactivating embryonic pathways in damaged heart tissue.

Contribution

The paper introduces the concept of 'embryonic recall' as a novel mechanism for myocardial repair using PICSO.

Findings

PICSO may enhance vascular activation and influence the fate of heart and endothelial cells.

Noncoding RNA is identified as a key signaling component in PICSO's regenerative effects.

Clinical outcomes suggest a need to redefine PICSO's goals and optimize its use.

Abstract

Pressure-controlled intermittent coronary sinus occlusion (PICSO) was initially developed to salvage ischemic myocardium. However, recent evidence suggests a more profound role: reawakening embryonic molecular pathways that facilitate myocardial regeneration. This review examines the paradigm shift in PICSO’s mechanism—from its traditional focus on infarct size reduction to its emerging role as a catalyst for myocardial repair through the reactivation of embryonic signaling. Findings suggested that myocardial decay could be ameliorated beyond salvage, revealing that PICSO enhances vascular activation in the coronary venous system, thereby influencing the fate of endothelial and myocardial cells. The theorem “embryonic recall” posits that PICSO induces molecular signals reminiscent of early cardiac development, offering a novel approach to cardiac repair in myocardial jeopardy. Noncoding RNA serves as a universal signaling event, thereby supporting the hypothesis. Yet, conflicting clinical outcomes highlight the need to redefine PICSO’s objectives, optimize device settings, and realize interventional strategies. The evolution of PICSO demands a radical shift in scientific perspective. Beyond ischemic salvage, its true potential may lie in harnessing regenerative mechanisms within the failing heart. Modern cardiology must adopt this dual role, bridging mechanical intervention with molecular rejuvenation to ensure its continued viability as a therapeutic option. PICSO, like the phoenix, may yet rise anew as a transformative force in cardiovascular medicine.

Figures